pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LILLY · news · pharmadog
← back to LILLY
News mentioning LILLY
793
stories
Jun 2, 26
Eli Lilly issues data sharing ultimatum to 340B hospitals
biopharma dive
Jun 2, 26
STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
stat
Jun 2, 26
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
stat
Jun 2, 26
STAT+: Online care is caught in the crossfire as states crack down on corporate medicine
stat
Jun 1, 26
STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
stat
Jun 1, 26
#ASCO26: Lilly's plenaries; Incyte's frontline data in lymphoma
endpoints
Jun 1, 26
#ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T update
endpoints
Jun 1, 26
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
stat
Jun 1, 26
STAT+: A turning point for pancreatic cancer patients
stat
Jun 1, 26
CDC says containing the spread of Ebola is top priority
stat
Jun 1, 26
Lilly licenses GLP-2 asset from Korean biotech Hanmi for $75M upfront
endpoints
Jun 1, 26
STAT+: Medicare still won’t say how much covering obesity drugs will cost
stat
May 29, 26
Post-Hoc: Lilly gets more secretive and hides Phase 1 pipeline
endpoints
May 29, 26
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
stat
May 29, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
May 29, 26
Pfizer, Innovent strike $10B cancer drug deal
biopharma dive
May 29, 26
STAT+: The woman behind the world’s biggest longevity competition
stat
May 28, 26
STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress
stat
May 28, 26
Lilly obesity meds Foundayo and Zepbound to gain CVS coverage
endpoints
May 28, 26
CVS obesity drug deal puts Lilly on equal footing with Novo
biopharma dive
May 19, 26
STAT+: A new ranking of pharma companies by R&D performance
stat
May 19, 26
STAT+: Eli Lilly tops prominent rankings on pharma R&D performance
stat
May 18, 26
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
stat
May 15, 26
STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors
stat
May 15, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
May 15, 26
STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
stat
May 14, 26
Makary’s departure and Cassidy’s tenuous Senate seat
stat
May 14, 26
Create Medicines raises $122M to bolster in vivo CAR-T therapies
biopharma dive
May 14, 26
STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more
stat
May 13, 26
U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changes
stat
← prev
page 24 of 27
next →
